| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8349598 | Pharmacological Reports | 2018 | 9 Pages |
Abstract
Therapeutically, metformin and α-LA could be administered in chronic colitis. The combination of currently used pharmaceutics with natural and synthetic potent antioxidant compounds will become a therapeutic strategy of choice for UC to improve the quality of life if sufficient clinical trials are available.
Keywords
NF-κBPBS-BSAMDAnuclear factor-kappa-BDAIIBDDSSCATα-LaEnzyme linked immunoassayalpha-lipoic acidinterleukinInflammatory bowel diseaseELISAOxidative stresstumor necrosis factor-alphaSODDextran sulfate sodiumSuperoxide dismutasedisease activity indexTNF-αmalondialdehydeMetforminCatalaseUlcerative colitis
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Fatma S. Samman, Samah M. Elaidy, Soha S. Essawy, Mohammad S. Hassan,